Ozempic shortages to continue: Butler

Novo Nordisk “simply doesn’t have the factories” to meet growing demand for Ozempic, Health Minister says  Shortages of Novo Nordisk’s diabetes medication, Ozempic (semaglutide) are likely to continue into 2025, while hormone replacement patches could be resolved by September, Mark Butler the Minister for Health and Aged Care warns.  Speaking with Heidi Murphy on 3AW